Hardly any confidence needed for a company growing at 20% topline with enterprise value at 1 x sales. Even if they shutdown entire global growth plans, they can make $15m/annum NPAT. At a mere 10 x NPAT, this accounts to a SP 3 x current value.
- Forums
- ASX - By Stock
- Ann: Change in substantial holding
Hardly any confidence needed for a company growing at 20%...
Featured News
Add MVP (ASX) to my watchlist
(20min delay)
|
|||||
Last
42.5¢ |
Change
-0.020(4.49%) |
Mkt cap ! $47.87M |
Open | High | Low | Value | Volume |
44.5¢ | 44.5¢ | 41.5¢ | $108.9K | 255.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3552 | 42.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.0¢ | 6998 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3552 | 0.425 |
3 | 99976 | 0.420 |
3 | 11628 | 0.415 |
4 | 35965 | 0.410 |
3 | 43598 | 0.405 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 5498 | 4 |
0.435 | 2958 | 2 |
0.440 | 6306 | 2 |
0.445 | 6742 | 2 |
0.450 | 1342 | 2 |
Last trade - 14.34pm 18/11/2024 (20 minute delay) ? |
Featured News
MVP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online